MapLight Therapeutics to present at two major healthcare investor conferences in May and June 2026

MapLight Therapeutics announced that its management team will participate in the 2026 RBCCM Global Healthcare Conference on May 19 and the 2026 Jefferies Global Healthcare Conference on June 3, both in New York. The company will present and hold one-on-one meetings with investors, with live webcasts and recordings available on their website. This participation highlights MapLight's ongoing efforts to engage investors as it advances clinical-stage treatments for central nervous system disorders. Investors can expect updates on the company's progress and strategic direction during these events.